Answers are grounded in this paper and cite their sources.
Background: Fevers are common in children with underlying diseases, so antipyretics are often used. However, no specific guidelines exist for the use of antipyretics in children. Objective: This study aimed to determine the profile of antipyretics used by paediatric inpatients at Universitas Airlangga Hospital and to identify possible side effects and interactions associated with antipyretics use. Method: This observational study was conducted from March to June 2023. Convenience sampling was used to collect retrospective data from patients’ medical records, which were then analysed descriptively. Result: A total of 87 paediatric patients met the inclusion criteria. All paediatric patients received intravenous metamizole as an antipyretic treatment (100.0%), with 3 x 8 - 20 mg/kgBW as needed (55.2%) being the most used dosage regimen. Metamizole as monotherapy was the most widely used pattern (80.5%), and it showed the shortest mean duration of therapy. Paracetamol was only used in switching (11.5%) and alternating (8.1%) patterns. Abdominal pain was the most actual suspected side effect of metamizole (3.4%). No potential drug interactions associated with antipyretics were found. Conclusion: In general, intravenous metamizole effectively reduced fever in most paediatric patients at Universitas Airlangga Hospital.
No takes yet. Share an insight, caveat, or question.
Puspitasari et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: